Medindia

X

New Experimental Drug to Treat Ebola Virus Shows Promise, Awaits FDA Approval

by Shirley Johanna on  May 21, 2015 at 6:36 PM Drug News   - G J E 4
An experimental drug has been found by a team of scientists that can successfully treat up to 90 percent of mice exposed to Ebola virus.
New Experimental Drug to Treat Ebola Virus Shows Promise, Awaits FDA Approval
New Experimental Drug to Treat Ebola Virus Shows Promise, Awaits FDA Approval
Advertisement

Bogdan A. Solaja, Rekha G. Panchal and colleagues note that the U.S. Food and Drug Administration has yet to approve any therapeutic drugs or vaccines against the Ebola virus that, since December 2013, has infected more than 25,000 people and taken the lives of more than 10,000. While some researchers are developing vaccines to prevent Ebola infections, others are focusing on treatments for the disease. They are investigating a number of compounds, including existing malaria and flu drugs.

Advertisement
Solaja's team has been looking into possible treatments by studying a class of small molecules called diazachrysenes, which they've found in lab tests to be non-toxic and effective against the most potent bacterial toxin, botulinum neurotoxin. They wanted to screen this family of compounds for possible anti-Ebola drug candidates.

The researchers narrowed down their search to a handful of diazachrysenes. In their study, 70 to 90 percent of the mice that received one of three of the experimental compounds survived infection and didn't show any obvious side effects.

The findings are published in the journal ACS Infectious Diseases.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All